On immunosurveillance in human cancer.
- 1 May 1982
- journal article
- Vol. 55, 329-33
Abstract
The extraordinarily high incidence of cancers of many different varieties--carcinomas and lymphomas--in organ-transplant patients being maintained for long periods of time with immunosuppressive drugs is briefly reviewed. The role of immunosurveillance as a primary defense mechanism against cancer in human beings is consistent with these observations and is in need of further investigation. Conceivably, this mechanism may play a somewhat different role in humans from what has been observed in most experimental animal models.This publication has 10 references indexed in Scilit:
- Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells.The Journal of Experimental Medicine, 1982
- Cyclosporin A.1981
- Cancer following successful cadaveric donor renal transplantation.1981
- KAPOSIʼS SARCOMA AFTER KIDNEY TRANSPLANTATION REPORT OF COMPLETE REMISSION OF CUTANEOUS AND VISCERAL INVOLVEMENTTransplantation, 1980
- REACTIVATION OF OCULAR MALIGNANT MELANOMA AFTER RENAL TRANSPLANTATIONTransplantation, 1980
- Malignant Neoplasms Following Cardiac TransplantationJAMA, 1978
- Multiple primary cancers of the lung, esophagus, and other sitesCancer, 1977
- Development of cancer as a complication of clinical transplantation.1977
- Non-adaptive rejection of small tumour inocula as a model of immune surveillanceNature, 1976
- Immunologic approaches to the management of primary and secondary tumors involving the skin and soft tissues: review of a ten-year program.1975